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Abstract This chapter describes the application of statistical methods for health
surveillance, including those for health care quality monitoring and those for dis-
ease surveillance. The former includes adverse event surveillance as well as the
monitoring of non-disease health outcomes, such as rates of caesarean section or
hospital readmission rates. The latter includes various types of disease surveillance,
including traditional surveillance as well as syndromic surveillance. The methods
described are drawn from the industrial quality control and monitoring literature
where they are frequently referred to as “control charts.” The chapter includes a de-
tailed background of that literature as well as a discussion of the criteria and metrics
used to assess the performance of methods of health surveillance methods.
1 Introduction
Health surveillance shares many characteristics with industrial process monitoring.
In both cases, the goal is to appropriately manage a process – whether it is, for
example, a surgical process or some industrial fabrication process – and it is desir-
able to detect degradations in process quality as quickly as possible. For this reason,
many of the same techniques are used, including the Shewhart control chart, and
other types of charts based on accumulating information such as the cumulative sum
(CUSUM) chart and the exponentially weighted moving average (EWMA) chart.
However, there are differences between health surveillance and industrial process
monitoring that must be taken into account. For example, when an industrial quality
control chart raises a signal, the process is usually stopped while an investigation is
made into the cause. In contrast, health monitoring, particularly disease surveillance,
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Fig. 1 A taxonomy of public health surveillance activities. Source: Fricker (2013, p. 6).
continues throughout an investigation. Another difference is that a typical disease
outbreak will naturally grow and recede even when no action is taken to mitigate
the outbreak while in the industrial case process degradations typically persist until
the cause is detected and corrected.
Figure 1, taken from Fricker (2013, p. 6), is a basic taxonomy of public health
surveillance, which includes the surveillance of adverse reactions to medical inter-
ventions (particularly drugs and vaccines) and how health services are used, as well
as disease (epidemiologic) surveillance. Brookmeyer & Stroup (2004, p. 1) quote
Thacker (2000) in defining public health surveillance as “the ongoing systematic
collection, analysis, interpretation, and dissemination of health data for the purpose
of preventing and controlling disease, injury, and other health problems.”
In this chapter, we describe the application of industrial process monitoring (also
referred to as statistical process control) methods to health care, where we bifurcate
the various health surveillance activities shown in Figure 1 into those for health care
quality monitoring and those for disease surveillance. The former includes adverse
event surveillance, such as death following surgery, as well as the monitoring of non-
disease health outcomes, such as rates of caesarean section or hospital readmission
rates. The latter includes various types of disease surveillance, including traditional
surveillance as well as syndromic surveillance. In so doing, we also discuss the
criteria and metrics used to assess the performance of methods of health surveillance
methods.
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2 Background on Industrial Process Monitoring
In any system, there is a certain amount of noise that is present that cannot be re-
duced without fundamentally changing the system. Occasionally, however, some
change is introduced into the system resulting in a change to the output. This change
could affect the mean response, the variability of the response, or it could influence
the process output in some other way. Monitoring industrial processes via control
charts dates back to the 1920s when Walter Shewhart suggested that there is a dis-
tinction between common causes of variability, the inherent noise in the system, and
special causes of variability, those sources which induce a change in the system.
(Shewhart, 1931).
Shewhart’s insight was to plot quality measures of the output, and to specify
upper limit and lower limits that within which the plotted measure is likely to be
if the process is in-control, that is, producing parts with the same mean and vari-
ance. Points outside these control limits would then be taken to indicate that the
process has changed. Often the control limits are placed three standards above and
below the process mean, since the probability of a random variable being beyond
three standard deviations is very small (e.g., the probability is 0.0027 if the normal
distribution is an accurate model for the outcomes).
The kind of chart that is used to monitor the process depends on the type of data
collected. These are discussed in the next few subsections.
2.1 Monitoring Continuous Outcomes
When the outcome is the measurement of some quantity, such as length, weight,
time, density, etc., then the data are said to be continuous. The quality control liter-
ature often uses the term variables data for continuous measures.
For continuous data, the typical procedure is to take subgroups of size n (often
n= 3 to 5) and from each subgroup compute the average x¯ and some measure of the
variability, such as the range (R= xmax− xmin) or the sample standard deviation s.
These statistics, x¯1, x¯2, x¯3, . . . and either R1,R2,R3, . . . or s1,s2,s3, . . ., are then plotted
in time order in order to monitor the mean and variance of the process.
If the process is normally distributed with a mean of µ0 and standard deviation of
σ0 when the process is in control, then the upper control limit (UCL) and the lower








The control limits for the “R-chart” are UCLR =D2σ0 and LCLR =D1σ0, while for
the “s-chart” they are UCLs = B6σ0 and LCLs = B5σ0. The constants D1,D2,B5,
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control at time 12
Fig. 2 An illustrative X-chart where the process goes out of control at time 12.
and B6 are functions of the subgroup size n, and are tabulated in most books on
statistical quality control (e.g., see Montgomery, 2009, Appendix VI, p. 702).
The basic idea of a control chart is to then monitor future observations. Those
that fall within the UCL and LCL are determined to only have common variability
and thus the process is assumed to be behaving normally. However, if one or more
points fall outside of the control limits, that is an indication that one or more special
causes of variability are present, and thus the process is not behaving normally.
Under these conditions, the control chart is said to signal and the process should be
investigated and the special causes of variability identified and rectified. Figure 2
is an example of an X-chart with “3-sigma” control limits where the control chart
signals an out-of-control condition at time i= 12.
In practice, of course, the parameters µ0 and σ0 are unknown and must be es-
timated from data taken when the process is in control. The iterative process of
collecting data, estimating parameters, discarding data for which there is an ex-
plainable cause, re-estimating the parameters is called Phase I. This process is often
more difficult than it might sound; see Jordan & Benneyan (2012) for a description
of the issues involved when health care data are being monitored.
The usual estimate for µ0 is the grand average of the subgroup means for data








The in-control standard deviation σ0 is estimated by
σˆ0 = R/d2,
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if the s-chart is used. As with the other constants, the constant d2 is tabulated in, for
example, Montgomery (2009, Appendix VI, p. 702).
Once the process parameters are estimated from historical data with reasonable
accuracy, that is, with a sufficiently large number of subgroups, the real-time mon-
itoring of the process begins. This is called Phase II and it is the phase that is
most often associated with the use of control charts. Recent studies indicate that the
needed sample sizes can be much larger than previously thought; see Champ et al.
(2005), Jensen et al. (2006), and Champ & Jones-Farmer (2007).
Subgrouping is widely recommended because a sample average is more likely to
signal a change (if there is one) than control charts based on individual observations.
There are times, however, when each individual data value should be plotted and a
decision made about the process. For example, if data points are taken very infre-
quently, it might be desirable to plot each one. In cases like this, the “individuals
chart,” or simply the “X-chart” can be applied. If the mean and standard deviation




Since the parameters are generally not known in practice, it is necessary to es-
timate them from the data (when the process is in control). The estimate for µ0 is
x¯, the sample average, but there are different approaches to estimating σ0. One ap-
proach is to simply compute the sample standard deviation of the observed data.
This, however, will overestimate σ0 if the process was not completely in-control
when the data were collected. Instead, the usual procedure is to first compute the
moving ranges
MRi = |xi− xi−1|, i= 2,3, . . . ,
and then estimate σ0 as σˆ0 =MR/1.128. This estimate of the variability and is less
likely to overestimate σ0.
Some authors suggest running an X-chart to monitor the process mean and a
chart of the moving ranges to monitor the process dispersion. Rigdon et al. (1994)
have shown that the MR-chart is nearly powerless to detect changes in variability.
They suggest plotting only an X-chart to monitor both mean and variability.
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2.2 Monitoring Discrete Outcomes
Rather than measuring the quality of an unit on a continuous scale, there are cases
where as each unit can be only be classified as conforming or nonconforming, where
conforming means that the unit meets the requisite quality standards. For example,
a requirement that the unit should be free of surface blemishes does not yield a
measurement. A unit either has or does not have surface blemishes. A similar type
of data occurs when, for example, one is counting the number of scratches in a roll
of sheet metal. Data such as these are called attributes data in the quality literature
and discrete data in much of the statistics literature.
In the situation where each unit is either conforming or nonconforming, the usual
procedure is to take a subgroup of size ni at time i and observe the number Xi of
nonconforming units. If the units are independent with constant probability (within
the subgroup) of being nonconforming, pi, then Xi has a binomial distribution with
parameters ni and pi. When the process is in-control, the probability is constant,
that is, pi = p0 for all i. The goal is to detect a change as quickly as possible if the
nonconforming probability shifts to p1, which could be larger or smaller than p0.
A chart of pˆi = xi/ni against the time index i is called a “p-chart.” The mean and
variance of pˆi are E (pˆi) = p0 andV (pˆi) = p0 (1− p0)/ni for an in-control process.













The max in the formula for the LCL is needed because the second expression in
Equation (2) can be negative for small values of p0 or ni. If the LCL is equal to 0,
then no signal can be raised for a decrease in the proportion nonconforming. It is
usually desirable to detect a decrease in p for two reasons: first, a low value of pˆ
could be due to measurement error (e.g., a new employee who misunderstands the
criteria for nonconforming), and second, a change in the process that leads to better
quality is worth knowing so that the change can be made permanent (or even more
widely implemented).
Often, the subgroup size ni is constant, in which case the control limits in Equa-
tions (1) and (2) are constant. However, there are cases where the ni will vary
from subgroup to subgroup. For example, in monitoring surgical outcomes, the time
frame might be fixed at one month, and the number of surgeries will vary from
month to month. In these types of cases, the control limits will vary.
In practice, the probability that an item is nonconforming is unknown, so its value
must be estimated from past data. The usual estimate is to take all values taken from
the process when it was in control and compute
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p¯0 =
x1+ x2+ · · ·+ xm
n1+n2+ · · ·+nm .
Of course, if ni = n for all subgroups, then this estimate of p0 is simply the average
of the pˆi.
Occasionally, the total number of nonconforming units Xi is monitored rather
than the proportion. This is called an “np-chart” since Xi = ni pˆi when the process is
stable. The np-chart is normally used only when the subgroup sizes ni are constant.
There are situations where the output is a count of the number of nonconformities
per unit. For example, the measurement might be the number of voids (air pockets)
in a plastic molded part; for any unit, there could be 0, or 1, or 2, etc., voids. That
is, there can be more than one nonconformity per unit. For count data such as this,
the Poisson distribution is often an appropriate model for the number of nonconfor-
mities Xi per unit at time i. The Poisson distribution has one parameter λ , which is
also the mean and variance of the distribution: E(Xi) = λ and V (Xi) = λ .











where λ0 is the Poisson distribution parameter when the process is in control. The
maximum function is needed in Equation (4) because λ0− 3
√
λ0 is negative when









where the estimate is calculated for the m Phase I data periods when the process in
control.
The Poisson distribution is often a reasonable model for the number of events
that occur in a fixed time interval, or the number of occurrences on a fixed area
of the output. There are cases, though, where the variance is larger than the mean.
This phenomenon is called overdispersion, and if this occurs for some data set, the
negative binomial distribution (a two-parameter distribution) is often used in place
of the Poisson.
The c-chart assumes that the sample consists of a single unit, and the number
xi of nonconformities on that unit is recorded. The sample at each time unit could,
however, consist of ni units, rather than a single unit. The statistic ui = xi/ni is then














All of the charts described in Sections 2.1 and 2.2 are commonly referred to as
Shewhart charts – named after Walter Shewhart, who first used them – and they
share the property that the decision made at the current time is based on data col-
lected only at the current time. If, for example, a point is inside the control limits,
then the process is deemed to be in-control and when the next data point is collected,
this point and all past data points are ignored.1
For Shewhart charts, the number of subgroups between signals has a geometric
distribution with parameter p which is the probability of being outside of the control
limits. The expected number of subgroups between signals is commonly referred to
as the average run length (or ARL), where ARL= 1/p, and the ARL is used to
quantify and compare the performance of control charts.
For the X¯-chart with 3-sigma limits, for example, the probability of signaling
when the process is in-control is p= 0.0027 and so the in-control ARL or ARL(0) is
1/p= 370. This is the average time until a false signal – it is a false signal because
the process is in-control – and thus ARL(0) is a measure of how well the control
chart performs when the process is in-control.
Now, if a process were to go out-of-control, say with the mean increasing by
one standard deviation (i.e., µ1 = µ0 +σ/
√
n), then the probability is p = 0.0227
that a subgroup mean will exceed the UCL (and negligible probability that the sub-
group mean would fall below the LCL: 0.00003). Under these conditions, the out-of-
control ARL or ARL(1) is 1/p≈ 44. (Here, ARL(δ ) is the average run length when
the process mean shifts by the amount δ standard deviations.) The result is that it
can take a Shewhart X¯-chart a long time to signal for small to moderate changes in
the mean.
2.3 Control Charts Based on Accumulating Data
In order to improve on the ability to detect small to moderate changes in processes,
charts have been developed that accumulate information across time, rather than dis-
carding all in-control past data. This section describes the two most popular: the cu-
mulative sum (CUSUM) and the exponentially weighted moving average (EWMA)
control charts.
1 Sometimes Shewhart charts are used with supplementary runs rules, such as “also signal if there
are eight points in a row on the same side of the center line.” In these cases, it is no longer true that
past data are ignored, but even with the addition of such rules, the charts just described are referred
to as Shewhart charts.
Health Surveillance 9
2.3.1 CUSUM Charts
The CUSUM chart is based on the sequential probability ratio test of Wald (1945)
which is designed to test the simple hypotheses H0 : θ = θ0 and H1 : θ = θ1. The
sequential probability ratio test is designed to do this sequentially in time; that is,
at each stage, the decision can be to accept H0, reject H0, or continue taking data.
Wald (1945) showed that the optimal form of the test is to compute the cumulative
sum




where L ji is the likelihood under H j, j = 0,1. The sequential probability ratio test
(SPRT) terminates when











where α and β are the desired (or target) probabilities of Type I and Type II errors,
respectively. (The values given for a and b given above yield values of α and β
that are only approximately correct; the true probabilities of Type I or Type II errors
will differ slightly from the target.) In the case of process monitoring, whether it
be quality or health, there is really never an option to “accept” the null hypothesis,
so the lower limit is ignored. Thus, the lower boundary is normally replaced by a
reflecting boundary, usually at zero.
Because the null hypothesis is never “accepted” and eventually the statistic Xi
will cross its boundary b, the probabilities of Type I and Type II errors are really
1 and 0, respectively. For this reason, the metrics of Type I and Type II errors are
never used in process monitoring. Rather, we look at properties of the run length
distribution. Since we want to detect quickly a large shift, the run length should be
small when the process change is large, and since we don’t want false alarms, we
want the run length to be large when there is no change. The ARL defined in Section
2.2 is a common metric, especially in the quality monitoring literature, but there are
other metrics that can be used. See Fraker et al. (2008) for a discussion of other
metrics.
The CUSUM control chart of Page (1954) and Lorden (1971) is a well known






where x1,x2, . . . is the process output, µ0 is the in-control mean, and C0 = 0. The
CUSUM expression in Equation (4) can also be calculated recursively as
Ci =Ci−1+(xi−µ0) .
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This version of the CUSUM chart involves plotting Ci against the time index i and
looking for changes in the slope of the data. This is rather difficult to do by eye, so
graphical procedures, such as the V-mask (Montgomery, 2009, p. 415) have been
developed.
An alternative to the V-mask is to accumulate two separate cumulative sums: one
to detect upward increases in the mean, and one to detect decreases. Suppose that µ0
and σ0 are the process mean and standard deviation when the process is in-control,
and suppose it is desirable to detect a change of k standard deviations in the mean,
i.e., a shift from µ0 to µ1 = µ0 + kσ0/
√
n if subgroups of size n are used. The two




















The CUSUM chart raises a signal when C+i > h or C
−
i < −h. Since in some cases
it is more desirable to detect quickly an increase in the mean than a decrease (or
vice-versa), it is possible to use different values of k and h for the upper and lower
CUSUMs.
For small to moderate shifts, the CUSUM chart will signal a change with a
shorter ARL than the Shewhart chart when the two charts have the same in-control
ARL. For example, the CUSUM chart with k = 0.5 and h= 5 yields
ARLCUSUM(0) = 465
ARLCUSUM(1) = 10.4
whereas the Shewhart with 3.069σ limits has
ARLShewhart(0) = 465
ARLShewhart(1) = 52.0.
Thus, the CUSUM will catch a one standard deviation shift in the mean, on av-
erage, in one-fifth the time as the Shewhart chart with the same ARL(0) perfor-
mance. Although the CUSUM will catch small to moderate shifts much quicker
than the Shewhart, the reverse is true when there is a very large shift. For example,
ARLCUSUM(4) = 2.0 whereas ARLShewhart(4) = 1.2. For this reason, the CUSUM and
the Shewhart charts are often used in tandem, often with limits of ±3.5 standard
deviations or higher on the Shewhart chart.
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The CUSUM can also be used to monitor process variability. For example, to
monitor an increase in process variability, following Hawkins & Olwell (1998,
p. 67), use the CUSUM recursion






As recommended by Hawkins and Olwell, the same value for k should be used in
these CUSUMs for monitoring variability as in the CUSUMs for the mean.
2.3.2 The Exponentially Weighted Moving Average Chart
The exponentially weighted moving average (EWMA) chart of Roberts (1959) cal-
culates weighted averages of the current data value (xi) and the previous EWMA
statistic (zi−1),
zi = λxi+(1−λ )zi−1, (7)
where λ is a smoothing constant between 0 and 1 and typically z0 = µ0. The statistic
zi can be written in terms of all previous xi values as
zi = λxi+λ (1−λ )xi−1+λ (1−λ )2xi−2+ · · ·+λ (1−λ )i−1x1+(1−λ )iµ0.
The weights on past data values decrease exponentially, hence the name of the con-
trol chart.
When the process is in-control






1− (1−λ )2i]σ20 .
The quantity
[
1− (1−λ )2i] approaches 1 as i→ ∞; this gives the asymptotic vari-
ance as
V (zi)≈ λ2−λ σ
2
0 .









2−λ [1− (1−λ )
2i],
while the asymptotic control limits are









The values of λ and L are chosen to give the desired in-control and out-of-control
ARLs. The EWMA chart has properties much like the CUSUM chart. ARLs for
small to moderate shifts are much smaller for the EWMA or CUSUM chart than for




Comparing these numbers to those of the CUSUM chart, note that the EWMA and
CUSUM charts have similar average run length properties.
Very small values of λ , such as λ = 0.05, for example, produce a nearly uniform
weighting of past observations, with very little weight on the current data value. As
a result, similar to the CUSUM, large shifts are difficult to detect quickly with the
EWMA chart.
2.4 Multivariate Control Charts
In even the simplest process there is frequently more than one quality characteristic
to be monitored and these quality characteristics are often correlated. For example,
in industrial process monitoring, measurements of dimensions on a plastic part are
generally affected by the pressure and length of time that the plastic was intruded
into the mold. If the time and pressure are both high, then all dimensions of the part
will tend to be on the high side. Similar issues arise in health and monitoring; for
example, when monitoring systolic and diastolic blood pressure.
Assuming the quality measures have a p-variate normal distribution with mean
vector µ0 and covariance matrix Σ, so that x ∼ Np (µ0,Σ), then the Mahalonobis
distance
T 2 = (x−µ0)′Σ−1 (x−µ0) (8)
is the distance from x to the distribution’s mean µ0, taking into account the covari-
ance. Two points with the same Mahalonobis distance will have equal probability
density. Note that observations of the multiple quality characteristics within a single
unit are correlated, but successive random vectors are independent.
A chart based on the T 2 statistic is called the Hotelling T 2 chart (Hotelling,
1947). If subgroups of size n are used, then the sample mean x¯i and is computed for
each subgroup and the T 2 statistic becomes
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T 2i = n(x¯i−µ0)′Σ−1 (x¯i−µ0)
If the parameters µ0 and Σ are known (which is unlikely in practice), then T 2 has
a χ2(p) distribution, so the UCL is
UCLT 2 = χ
2
α(p)
Since T 2 measures the distance from the middle of the distribution, there is no LCL.
















where x¯ j and S j are the sample mean vector and sample covariance matrix within
the jth subgroup, then the T 2 statistic becomes
T 2i = (x¯i− ¯¯x)′ S¯−1 (x¯i− ¯¯x)




Champ et al. (2005) showed that very large sample sizes are needed in order to make
the T 2 with estimated parameters behave like the T 2 chart with assumed known
parameters.
The T 2 chart is a Shewhart chart in the sense that the decision at time i depends
only on data from time i; no accumulation of data is done. It is also directionally
invariant, that is, the run length distribution depends only on the magnitude of the
shift, measured by the Mahalonobis distance
(µ1−µ0)′Σ−1 (µ1−µ0)
and not on the direction of the shift.
The CUSUM chart from Section 2.3.1 has been generalized to the multivari-
ate setting. For example, Crosier (1988) proposed a multivariate CUSUM (or
MCUSUM) control chart that at each time i calculates the cumulative sum
C∗i = Ci−1+xi−µ0
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where µ0 is the mean vector and Σ0 is the variance-covariance matrix when the
process is in-control. It then “shrinks” the cumulative sum by
Ci =
{
C∗i (1− k/dt), di > k
0, di ≤ k , (9)






The control chart starts with C0 = 0 and it signals a change has occurred when
Si ≥ h, for some threshold h.
The literature contains a number of other MCUSUM control charts. In fact,
Crosier’s MCUSUM control chart described above is one of a number of other
multivariate CUSUM-like algorithms he proposed, but Crosier generally preferred
the above procedure after extensive simulation comparisons. Pignatiello & Runger
(1990) proposed other multivariate CUSUM-like algorithms but found that they per-
formed similar to Crosier’s. Healy (1987) derived a sequential likelihood ratio test
to detect a shift in a mean vector of a multivariate normal distribution. However,
while Healy’s procedure is more effective when the change is to the precise mean
vector to be detected, it is less effective than Crosier’s for detecting other types of
shifts, including mean shifts that were close to but not precisely the specified mean
vector.
As with the CUSUM, the EWMA chart from Section 2.3.2 is also easily extended
to the multivariate case, and the resulting chart is called the multivariate EWMA
(or MEWMA) chart (Lowry et al. , 1992). Similar to Equation (7), the MEWMA
statistic is defined as
z0 = µ0,
zi = λxi+(1−λ )zi−1,
where λ is a scalar value, 0 < λ ≤ 1. Then at time i, the T 2 statistic is calculated,
analogous to Equation (8), by









A signal is raised on the MEWMA chart whenever T 2 exceeds the value h. Just as
for the univariate EWMA chart, the parameters λ and h are chosen to produce some
of the desired ARL properties of the chart. Note that it is possible to use the exact
covariance matrix or the asymptotic covariance matrix
Σz ≈ λ2−λ Σ.
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in the computation of the T 2 statistic in Equation (10). Thus, there are actually two
versions of the MEWMA chart. Tables for choosing λ and h are given in Lowry
et al. (1992) and Montgomery (2009).
The MCUSUM and MEWMA can detect small to moderate shifts in the mean
more quickly than the Hotelling T 2 chart. For example, when p= 6, λ = 0.2, h=





the MEWMA ARL is 14.6. In contrast, the Hotelling T 2 chart with UCL = h =
18.55 gives an ARL of 74.4 for the same shift. Both control charts have an in-control
ARL of 200.
3 Health Care Monitoring
In quality monitoring, it is usually assumed that the input materials are homoge-
neous, and that the resulting process output has a fixed mean and variance. Health
care monitoring of individual patients, on the other hand, must account for differ-
ences among patients. This case mix, that is, the variability in risk factors among
the patients being monitored, must be taken into account. Otherwise, providers who
take on patients with high risk factors would be penalized when fewer patients sur-
vive.
Thus, the first important difference from industrial process monitoring is that
health monitoring data must be risk-adjusted, so that comparison among or across
providers is done fairly. In this context, risk adjustment means building a model
using historical data relating risk factors, such as age, body mass index (BMI), di-
abetes status, to the outcome variable. What is charted, then, is some statistic that
does not depend on the levels of the predictor variable.
3.1 Risk-Adjusted Charts
Before any risk-adjusted chart can be applied, a model must be developed that re-
lates the probability pi of the adverse outcome for patient i to the predictor variables
xi1,xi2, . . . ,xip. A logistic model assumes that this relationship is of the form
logit(p0i) = log
p0i
1− p0i = β00+β01x1+ · · ·+β0pxp. (11)
The parameters β00,β01, . . . ,β0p must be estimated from some baseline set of data
taken when the process or patient is stable. We will look for a change in the param-
eters from β00,β01, . . . ,β0p to β10,β11, . . . ,β1p. If we write xi = [1,xi1, . . . ,xip]′ and
β 0 = [β00,β01, . . . ,β0p]
′ then we can write the logistic model in Equation (11) as





Consider, for example, the cardiac survival data from Steiner et al. (2000). The
response variable is a dichotomous variable that indicates death within 30 days (Y =
1) or survival past 30 days (Y = 0).2 The predictor variable is the Parsonnet score, a
measure of a patient’s condition. The Parsonnet score is a function of pre-operative
measures of the patient’s health, and including age and a number of categorical
variables such as gender, diabetes status, hypertension status, etc. Higher Parsonnet
score are associated with a weaker condition, and a higher chance of dying in the 30-
day follow-up period. Generally, the Parsonnet scores vary from 0 to about 60, and
follow somewhat closely the exponential distribution with mean 10. See Geissler
et al. (2000) for a survey of other risk measures.
Figure 3 shows the Parsonnet score on the x-axis (with some jitter to avoid over-
lapping points) against the response (Y = 1 if the patient died within 30 days, and
Y = 0 if the patient survived 30 days). The curve in this figure is the logistic fit of





1+ exp(−3.67+0.77xi) . (14)
Once the in-control parameters β0 are estimated, we can monitor prospectively
the outcomes of patients with varying risk factors. For example, suppose that the
risk variables for patient i are contained in the vector xi and we have estimates
βˆ 0 =
[
βˆ0, βˆ1, . . . , βˆp
]
. From this, we can estimate from Equation (12) the probability
pi0 that patient i will experience the adverse effect (given that the process is in-
control). The outcome yi, where yi = 1 if the adverse outcome occurs, and yi = 0 if
it doesn’t, is compared to the expected outcome. The various ways this comparison
is done, and the statistic that is computed determines the type of chart.
In industrial process monitoring, the usual procedure is to compare data from a
process with past data from that process when it was stable, that is, operating in
a state of statistical control. Often in health care monitoring, the process output is
compared to an external standard, not past data from the process (hospital, surgeon,
etc.). This affects the interpretation of a point outside the control limits. In indus-
trial process monitoring, a point outside the limits is evidence that the process has
changed. When data are compared to an external standard, a point outside the limits
is evidence that the process is not meeting the standard.
The next subsections cover risk-adjusted p-charts, CUSUM charts, EWMA
charts, VLAD charts, and charts based on the sets method.
2 Attributes or discrete data are much more common in health care monitoring. In fact, many
variables are dichotomized, that is changed from a continuous measurement into a yes/no mea-
surement. Here, for example, the variable of interest is whether or not the patient survived for 30
days, not the actual survival time.
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Fig. 3 Outcome (death within 30 days of surgery) verses Parsonnet score. Some “jitter” has been
introduced to avoid many overlapping points.
3.1.1 Risk-adjusted p-Charts
One approach to monitoring binary outcomes y1,y2, . . . is to use subgrouping and to
compare the observed proportion of adverse outcomes to the expected proportion.
When health care monitoring is done using risk adjustment, the successive observa-
tions yi are independent but not identically distributed because of the varying risk
factors. (This is in contrast to the quality monitoring situation where successive ob-
servations are assumed to be independent and identically distributed.) For patients
i = 1,2, . . . we have yi ∼ Bin(1, pi). The total number of adverse outcomes in the





























pi (1− pi) .
Because the varying risk factors cause the pi to vary, the sum ∑ni=1 yi does not
have a binomial distribution. For the usual p-chart in industrial monitoring, the Cen-
tral Limit Theorem is applied to argue that the proportions of nonconforming units
in each subgroup is approximately normally distributed, and therefore that three
standard deviation limits above and below the mean should include nearly all of the
the observed proportions. Similar reasoning applies here.
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For the risk-adjusted p-chart, the plotted statistic is the proportion of adverse

















































pi (1− pi). (15)
Here, the sums are over all of the outcomes in the current subgroup. Often, the
lower control limit is negative, making it impossible for the risk-adjusted p chart
to detect a decrease in the probability of an adverse outcome (i.e., an improvement
in outcomes). Note that the control limits will vary from one subgroup to the next
because of the varying risk factors.
The choice of the subgroup size n involves some trade-offs. If n is large, then
there will be a lot of information in each subgroup, making it likely that a shift will
be detected on that subgroup. Large subgroups, however, mean that data points for
the chart will be obtained infrequently (since n patients must be accumulated before
a subgroup is completed) making quick detection more difficult. On the other hand,
small subgroups mean that the plotted statistics will be obtained more frequently
but each will contain less information. See Jordan & Benneyan (2012) for a more
detailed description of the issues involved in selecting the subgroup size.
To illustrate the risk-adjusted CUSUM chart, we return to the Steiner et al.
(2000) cardiac surgery data and the logistic regression model fit in Equations (13)
and (14). Now, consider, for illustration, the first patient, who had a Parsonnet score
of 19. Using the logistic model from the first two years’ worth of data, we would
estimate this person’s probability of death to be
p01 =
exp(−3.67+0.077×19)
1+ exp(−3.67+0.077×19) = 0.09912
assuming, of course, that the process is operating at the standard defined by the
logistic regression model in Equation (13). This patient did survive past 30 days, so
y1 = 0.
3 We use pˆi rather than the pˆ used in industrial quality monitoring because we reserve pi to be the
(estimated) probability of adverse outcome or patient i.
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Subgroup size = 20
Fig. 4 p-chart for first 41 subgroups of 20 patients each.
If we were to use a subgroup size of n = 20, then patients 1–20 would be in
the first subgroup, patients 21–40 would be in the second subgroup, etc. The num-
ber of adverse outcomes in the first 20 patients was one since only patient 12 died
within the 30-day window. The proportion of deaths was then pˆi1 = 1/20 = 0.05.































and the lower control limit is zero since the formula for LCL in Equation (15) yields
a negative number. Figure 4 shows the p-chart for the first 40 subgroups. The 27th
observation was slightly above the UCL, indicating that the process is not operating
according to the standard set by the logistic regression model. This is indicated on
the chart by the solid blue dot.
Figure 5 shows the resulting p-charts for the entire data set for subgroups of size
n = 20, 40, 80, and 160. Note that the lower control limits are zero in most cases
for n≤ 80. Only for larger subgroup sizes is the risk-adjusted p chart able to detect
an improvement in surgical outcomes. Among the four p-charts in Figure 5 there
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are five signals (three on the n = 20 chart and two on the n = 80 chart, which in
this case may be false alarms. In all five cases, the plotted point is barely above
the upper control limit, and the signals do not match up in chronological time. We
would expect more false alarms for smaller sample sizes, such as n = 20, simply
because there are more plotted points and more opportunities for a false alarm.
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Subgroup size = 160
(1000) (2000) (3000) (4000) (5000) (6000)
Fig. 5 p-charts for cardiac survival data. Response is whether the patient survived for 30 days. The
four plots show the p-chart for subgroup sizes of 20, 40, 80, and 160.
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3.1.2 Risk-Adjusted CUSUM Charts
We begin by looking at the CUSUM chart for a constant probability of an adverse
outcome. Suppose that at time i we observe the variable yi which is equal to 1 if some
adverse outcome occurs in the given time window, and 0 if the adverse outcome does
not occur. Then, yi ∼Bin(1, p) , or equivalently, yi ∼Bern(p). We would like to test




be the odds ratio, then our null and alternative hypotheses for testing whether the
odds ratio has changed by a factor of R can be written as

























, if yi = 0.
(17)
The non-risk-adjusted Bernoulli CUSUM for detecting an increasing in the prob-
ability p is then defined by
X0 = 0
Xi = max(0,Xi−1+Wi) (18)
while the CUSUM for detecting a decrease in p is defined as
X0 = 0
Xi = min(0,Xi−1−Wi) (19)
In Equation (18), p1 > p0, whereas in Equation (19), p1 < p0. For the CUSUM with
limit h= 5 for the upper chart and h=−5 for the lower chart the in-control ARL is
approximately 6,939 (estimated by simulation).
Consider now the risk-adjusted CUSUM chart. We assume that a logistic regres-
sion model has already been developed that relates the predictor variable(s) to the
response and that the model parameters have been estimated. The probability pi of
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an adverse outcome, computed from the logistic model, is incorporated in the likeli-
hood ratio. Note that the parameters β0,β1, . . .βp in the logistic model are assumed
to be known, much as the mean and variance in the X¯ and R charts are assumed
known. Note also that Yi ∼ Bin(1, p0i), so that E (Y0i) = p0i. The resulting weights
Wi are as in Equation (17), except now the weight for patient i depends on the proba-
bility of the adverse event for that patient. Often, the change we would like to detect
is expressed in terms of the odds ratio R, rather than in terms of ratio of probabilities












= exp [(β10−β00)+(β11−β01)x1i+ · · ·+(β1p−β0p)xpi] .
Here β 0 is the parameter vector when the process is in control (or not operating at
the standard) and β 1 is the parameter vector when the process is out of control (or
not operating at the standard). Thus, R is independent of the levels of the predictor
variables xi if and only if β11 = β01, . . . ,β1p = β0p; in other words, the only change
in β is in the constant term β0 which, when the process shifts from β00 to β10.
The risk-adjusted CUSUM is then defined the same as in Equations (18) and
(19), although the weights will differ; in this case the weights will depend on the
patient’s condition through the predictor variables.
Consider, for illustration, the cardiac surgery data from Section 3.1. If we set
up the risk-adjusted CUSUM chart to detect a doubling of the odds ratio (that is,
R= 2), then since the first patient survived for 30 days the weight for patient 1 is
W1 = y1 logR− log(1+(R−1)p01)
= y1 log2− log(1+ p01)
= 0× log2− log(1.09912)
= −0.0945.
Note that had this first patient died within the 30-day window, the weight would
have been
W1 = 1× log2− log(1.09912) = 0.9054.
Thus, since the first patient did survive past 30 days, the CUSUM at time i = 1,
is max(0,0− 0.0945) = 0. The second patient had a Parsonnet score of x2 = 0 so
the probability of survival was p2 = exp(−3.67)/(1+exp(−3.67)) = 0.02484. This
patient, who also survived for 30 days, produces a weight of
W2 = 0× log2− log(1.02484) =−0.0245.
This weight is less in magnitude than the weight for the first patient who had a
higher Parsonnet score. Had the second patient died within the 30-day period, the
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weight would have been
W2 = 1× log2− log(1.02484) = 0.9754
Thus, the death of a low risk patient contributes more to the upper CUSUM than
the death of a higher risk patient. Analogously, the survival of a higher risk patient
contributes more in magnitude to the lower CUSUM than the survival of low risk
patient.
The lower CUSUM might set up to detect a halving (i.e., R = 0.5) of the odds
ratio. In this case, the weight would be
W1 = y1 logR− log(1+(R−1)p01)
= y1 log0.5− log(1−0.5p01)
= 0× log0.5− log(1−0.5×0.09912)
= 0.05083.
This lower CUSUM would then be X1 = min(0,0−0.0503) =−0.05083.
The risk-adjusted CUSUM charts (both the lower and the upper) for the cardiac
data are shown in Figure 6. The control limits of h= 5 and h=−5 were designed to
give an in-control ARL of about 6700 (determined by simulation). We see in Figure
6 that just before the 4000th patient, the upper CUSUM exceeds the upper control
limit of h= 5, indicating a increase in the probability of death; that is, a lowering of
quality. Shortly thereafter, the lower CUSUM begins to pick up steam and eventually
(around patient 5000) drops below the lower limit of h=−5, indicating a decrease
in the probability of death; that is an improvement of quality.
Woodall et al. (2015) point out that it is often claimed that the risk-adjusted
CUSUM is optimal, citing Moustakides (1986). The work of Moustakides, how-
ever, assumes independent and identically distributed observations. In the case of
the risk-adjusted CUSUM, the patients’ risk factors vary, which means that the ex-
pected values of the yi vary. The random variables y1,y2, . . . are thus not identically
distributed, although they are assumed to be independent.
3.1.3 Variable Life Adjusted Display (VLAD) Charts
If pi is the probability of the adverse outcome, obtained from some model relating
the risk factors xi for patient i, then the expected value of yi is
E (yi|xi) = pi.
Thus, yi is the observed outcome and pi is the expected outcome at time i. A plot of
the accumulated values of
Observedi−Expectedi = Oi−Ei = yi− pi
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Fig. 6 risk-adjusted CUSUM of cardiac survival data. Response is whether the patient survived
for 30 days.
on the y-axis and time i on the x-axis is called a variable life adjusted display
(VLAD), although it goes by other names, such as the cumulative risk-adjusted






represents the difference between the cumulative number of deaths and the expected
value of this quantity. For this reason, the cumulative sum can be interpreted as the
number of lives lost above that which was expected. The vertical axis is often labeled






then the vertical axis is labeled as “Lives Saved.”
Control limits can be placed on the VLAD chart, although many authors, such as
Winkel & Zhang (2007) recommend against this. The limits are based on the mean
























p j(1− p j).








p j(1− p j).
When i is large, the variance of Vi is approximately np¯(1− p¯), so the standard de-
viation is approximately
√
np¯(1− p¯). If the control limits are placed at plus and







Because these control limits create a convex in-control region opening to the right,
they are often called “rocket tails.” The reason these limits are not recommended is
that if the change occurs when the plotted statistic is currently near the middle or
opposite end of the shifted direction, then the chart will take a long time to signal.
This phenomenon is called inertia in the quality literature.
The VLAD chart for the cardiac surgery data is shown in Figure 7. There seems
to be a decrease in excess mortality starting just before patient 5,000, though it is
important not to over interpret the VLAD plot. Figure 8 shows the same VLAD
chart as in Figure 7, with an additional four plots simulated with nothing but noise.
Even though there some ups and downs in Figure 8 that seem to be as distinct as
those in Figure 7, in the last four plots there was no change in either the surgical
performance or the distribution of risk factors.
Woodall et al. (2015) suggest that the VLAD chart is easily understand and can
serve as a visual aid to get an overall sense of the data. However, since there is no
good way for the VLAD to raise an out-of-control signal, the VLAD should be used
together with some other method, such as the risk-adjusted CUSUM, that can raise
a signal.
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Noting that yi is the observation Oi at time i, and p0 = E (yi) = Ei, we can write this


















The weights from the risk-adjusted CUSUM are given in Equation (??). Note
that there is no value of (p0, p1) which makes the coefficients A and B in Eqation
(20) both equal to 1, which are the coefficients of Oi and Ei in the VLAD. This
implies that the VLAD is never equivalent to the risk adjusted CUSUM procedure.
















Fig. 7 Variable life adjusted display of cardiac survival data. Response is whether the patient
survived for 30 days.
3.1.4 The Risk-Adjusted EWMA Chart
The EWMA chart described in Section 2 can be applied to risk adjusted data. One
way to do this is to compute the observed statistic Oi = yi minus the expected statis-
tic Ei = pi, as in the VLAD chart, and to maintain an EWMA statistic on these
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Fig. 8 Variable life adjusted display of cardiac survival data. Response is whether the patient
survived for 30 days.
values. This is the approach described by Steiner (2014) More general approaches
are described in Grigg & Spiegelhalter (2007) and Steiner & Jones (2010). The
EWMA statistic is computed by
z0 = 0
zi = λ (yi− pi)+(1−λ )zi−1 .
Since health monitoring involves a fairly substantial amount of data, we usually
choose small values of λ . This allows for small changes in the outcome to be de-
tected quickly. It also makes for a nearly uniform weighting of past observations.
For example, if λ = 0.02, then the current observation gets a weight of λ = 0.02;
the previous observation gets a weight of λ (1−λ ) = 0.02×0.98= 0.0196; the one
before that a weight of λ (1−λ )2 = 0.02×0.982 = 0.0192. The weights do die out
exponentially as we move back in time, though. For instance, the observation 50
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time units in the past has a weight of λ (1−λ )50 = 0.02×0.9850 = 0.00728. Typi-
cally, values of λ between 0.01 and 0.10 are used for such an EWMA chart. Figure
9 shows the risk-adjusted EWMA chart for the cardiac data using λ = 0.02.
Compare the EWMA chart on yi− pi to the VLAD; the VLAD places a uniform
weight on the current and all previous observations, whereas the EWMA places
weights that decay (albeit slowly when λ is small) back in time. The EWMA chart
can also be based on scores other than the yi− pi as suggested here. For example,
we could use the scores obtained from the likelihood ratio as given in Equation (17).
*****
Although the EWMA chart, as described in the quality monitoring literature, as-
sumes a normally distributed response, such an assumption is not needed. Since we
are taking the weighted average of a large number of observations, the sample statis-
tic Zi will be approximately normally distributed even if the original distribution is
not. This is an important characteristic for the risk-adjusted EWMA chart since the
distribution of yi− pi is distinctly nonnormal. When a patient survives, the statistic
is usually just under 1.0, and when a patient dies, the statistic is usually just under
0.0. Figure 10 shows a histogram of yi− pi showing the extent of the nonnormality.























Fig. 9 The risk-adjusted EWMA chart applied to the observed minus expected statistics yi− pi.
3.1.5 The Risk-Adjusted Sets Method
Chen (1978) proposed the “Sets” method for surveilling the occurrence of congeni-
tal malformations. The idea behind the sets method is to monitor the times between
successive events, that is the number of elements in the “set” of patients between
events. Normally, the set includes the first patient after the previous event and the
next patient who had the event. For the non-risk adjusted chart, the probability of
















Fig. 10 Histogram of the observed minus expected statistics yi− pi showing a highly nonnormal
distribution.
to the number of patients G in the set has a geometric distribution with probability
p0, where p0 is the probability of the adverse event when the process is in control.
The rule for inferring “out of control” is that n successive G’s are less than or equal
to the value T . The values chosen for n and T then determine the chart. The sets
method was studied further by Gallus et al. (1986). Later Chen (1987) compared
the sets method with the risk-adjusted CUSUM chart and found that “The sets tech-
nique is ... more efficient than monthly cusum when the number of cases expected
in a year is no greater than five, but less efficient otherwise.”
Figure 11 shows sets plot for the first 700 or so patients in the cardiac data set.
The plotted statistic increases by one for each additional patient who survives. After
each death, the y-coordinate is reset to zero. A plot such as this is called a “grass”
plot, since the plotted lines look like blades of grass. It is helpful to put a horizontal
line on the graph at the value of T and to make notes of those cases where the set
has size less than or equal to T . If we chose T = 20 and n = 8, then we would say
“out of control” when we get eight straight sets of 20 or fewer patients. In Figure 11
the out of control flag would be raised at time 286 when eight consecutive sets had
20 or fewer patients.
The risk-adjusted sets method of Grigg & Farewell (2004) involves computing
the size of the set beginning with the first patient after the previous event and ending
with the patient having the current event. Now, the “size” of the set is defined to be
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where p0i is the probability of the adverse event for patient i under the assumption
that the process is operating at the standard level. This method of scaling is based on
the intuitive assumption that a patient with a high probability of the adverse event
who does not experience the event should add more to the risk pool for that set than
a patient with a lower probability. This scaling also reduces to the unadjusted sets
method because if all patients have the same probability, say p0, then the expected



















The size of the set of patients between adverse events is then
S j = ∑
i∈Set j
wi
For the risk-adjusted sets method, a grass plot is defined to be a plot of the accumu-
lated risk between events. The same out of control rule, n consecutive sets whose
total risk is T or less, is used here. Figure 12 shows the risk-adjusted grass plot for
the cardiac data.
3.2 Other Aspects of Health Care Monitoring
Donabedian (2005, 1988) suggests three categories for assessing the quality of
health care: structural, process, and outcomes. The structural category refers to the
availability of equipment, nurse-to-bed ratios, etc. The process category involves
measurements on variables related to the delivery of health care; for example lab
turnaround time, “door-to-balloon” time (for certain myocardial infarction patients),
and hand washing compliance. The outcomes category involves characteristics of
the patients after receiving treatment, and includes, for example, 30-day survival af-
ter surgery, hospital readmission within 30 days, ventilator-associated pneumonia,
etc.
We will add to this list of categories one which we call personal, whereby the
health characteristics of a single patient are monitored in much the same way as
process or outcomes are monitored. For example, a patient may monitor his blood
pressure daily – any departure from normal could be reported to the physician –
where Figure 13 shows individuals charts of systolic and diastolic blood pressures
for a hypothetical patient. Values that plot outside the three standard deviation limits
above and below the mean would suggest a potential health problem and, in Figure
13, we see that the last data point on the systolic blood pressure exceeds the upper
control limit, causing a signal that the process has changed.
However, since blood pressure is inherently a two-dimensional process (systolic
and diastolic), a multivariate control chart, such as those described in Section 2.4,
would be appropriate. Figure 14 shows the bivariate plot of systolic and diastolic
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Fig. 11 Grass plot for the unadjusted sets method for the cardiac data.





































Fig. 12 Grass plot for the adjusted sets method for the cardiac data.
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Fig. 13 Individuals charts for systolic blood pressure (SBP) and diastolic blood pressure (DBP).





























Fig. 14 Hotelling T 2 chart for variables systolic blood pressure (SBP) and diastolic blood pressure.
blood pressure measurements with older observations in a lighter shade of gray.
The other part of Figure 14 shows the Hotelling T 2 chart of
T 2 = [xSBP− x¯SBP, xDBP− x¯DBP]S−1 [xSBP− x¯SBP, xDBP− x¯DBP]′
where xSBP and xDPB are the observed systolic and diastolic blood pressures at each
time period, while x¯SBP and x¯DPB are the mean systolic and diastolic blood pressures
and S is the sample covariance matrix taken when the patient is in his or her normal
condition.
In Figure 14, Hotelling T 2 raises a signal at the very last data point. The ellipse
in the first part of Figure 14 is the “control ellipse” in the sense that a point inside
the ellipse will lead to a T 2 value below the upper control limit, and a point outside
the ellipse will lead to a T 2 value above the upper control limit.
The ease with which personal data can be collected may lead to tremendous op-
portunities in the monitoring of data on individuals. This can lead to the availability
of massive data sets, often called “big data,” which have the potential to monitor
health to a greater extent. To illustrate one possible use of monitoring personal data,
consider the touch sensitive floor called a “magic carpet” that can be installed in the
home or in independent or assisted living communities. Baker (2008) described this
concept in his book The Numerati. This special flooring can record the exact time,
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location, angle and pressure of every step the person takes. Numerous characteris-
tics about a person’s gait can be gleaned from such data. Obviously, the absence of
any such data on a given day is cause for alarm (although it could also just indi-
cate the person was on vacation). Data showing slower steps, or uneven steps, could
indicate a problem as well. Intel has developed SHIMMER (Sensing Health with
Intelligence, Modularity, Mobility and Experimental Reusability) technology (see
Boran, 2007). These involve wearable Bluetooth devices that can monitor many
health characteristics. Large data sets that would be obtained using such devices
present challenges for data analysis and opportunities for improving health care
while reducing costs.
4 Disease Surveillance
Many of the methods used in disease surveillance have been drawn from or are
related to those of industrial process monitoring. However, there are important dif-
ferences between the typical industrial process monitoring application and disease
surveillance, which means that the standard industrial methods described in Sec-
tion 2 usually must be modified before being applied to disease surveillance. In this
section, to distinguish between the two different uses, methods designed for or dis-
cussed within an industrial context are referred to as control charts while methods
designed for or discussed in a disease surveillance context are referred to as detec-
tion methods.
A key difference in the two applications is the assumption that the observations
are independent and identically distributed (or iid). In industrial process monitoring
applications, with appropriate implementation of the procedures, this assumption
can often be met with the raw data. But this is often not the case for disease surveil-
lance data. There are two main reasons for the difference.
• First, while industrial process monitoring and disease surveillance are both time
series data, in industrial monitoring the process is explicitly controlled and thus
the raw data is the noise resulting from the process when it is in-control. As
such, the data can reasonably be assumed to be identically distributed. In con-
trast, background disease incidence process in disease surveillance is inherently
uncontrollable and thus the data itself is usually autocorrelated and so it cannot
be identically distributed.
• Second, industrial data are usually samples from a process, and the sampling
times are controlled with the data taken far enough apart in time so that the re-
sulting data is at least approximately independent from one sample to the next.
In contrast, particularly in the case of biosurveillance, in the interest of making
disease detection as fast as possible, all the available data is used so that autocor-
relation is virtually unavoidable.
Thus, disease surveillance data generally violates the iid assumption underlying the
control charts described in Section 2. However, it is often reasonable to assume
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that the residuals from a model that removes the systematic effects from disease
surveillance data are iid.
The lack of independence between observations is only one way that disease
surveillance may differ from the typical industrial process monitoring assumptions.
As shown in Table 1, other differences include a lack of time series stationarity,
the types of statistics to monitor in order to most effectively detect outbreaks, and
how the transient nature of outbreaks affects detection performance. For best perfor-
mance, detection methods must be designed to accommodate these and other disease
surveillance data characteristics.
Classical Control Chart Typical Disease Surveillance
Data Characteristics Data Characteristics
1. The in-control distribution 1. There is little to no control
of the data is (or can reasonably over disease incidence and the
be assumed to be) stationary. disease incidence distribution
is usually non-stationary.
2. Observations can be drawn from 2. Autocorrelation and the potential
the process so they are need to monitor all the data
independent (or nearly so). can result in dependence.
3. The asymptotic distributions of 3. Individual observations may be
the statistics being monitored monitored; if so, asymptotic
are known and thus can be used sampling distributions not
to design control charts. relevant.
4. Monitoring the process mean 4. Little is known about which
and standard deviation is statistics are useful; often
usually sufficient. looking for anything unusual.
5. Out-of-control condition remains 5. Outbreaks are transient, with
until it is detected and disease incidence returning to
corrective action is taken. its original state when the
outbreak has run its course.
6. Temporal detection is the 6. Detecting both temporal and
critical problem. spatial anomalies are critical.
Table 1 Characteristics of classical industrial process monitoring data compared to disease surveil-
lance data. Source: modified from Fricker (2013, p. 154).
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4.1 Modeling Disease Incidence
Disease surveillance data often have systematic effects (i.e., explainable trends and
patterns). These can include day-of-the-week effects, where patient health-seeking
behavior systematically varies according to the day of the week. It may also include
seasonal effects where, for example, influenza-like illness is generally higher in the
winter months of the year compared to the summer months.
These trends and patterns can be used to build models and the models can then
be used to better understand and characterize historical trends, to assess how the
current state compares to historical trends, and to forecast what is likely to occur
in the near future. For example, one might use a model f to forecast the disease
incidence at time i, xˆi, using past disease incidence (xi−1,xi−2,xi−3, . . .) as well as
other covariates (y1,y2,y3, . . .):
xˆi = f (xi−1,xi−2,xi−3, . . . ,y1,y2,y3, . . .).
For example, many diseases have a clear seasonal component to their incidence
rate. Some diseases such as influenza or pertussis peak in the winter, whereas oth-
ers, such as E. coli peak in the summer. Serfling (1963) first considered the use of
trigonometric models that account for the seasonality in disease rates. He applied














for weekly counts of influenza. For his purpose, the counts were large enough that
the normal distribution was reasonable. For diseases that are much rarer than in-
fluenza, such an assumption is unreasonable. Rigdon et al. (2014) considered the
reportable diseases that are monitored by the state of Missouri. For most diseases
a first-order model, that is p = 1 in Equation (21) is sufficient, but in some cases a
second-order model (p= 2) is needed. They assumed Poisson distributed counts for
the reportable diseases and constructed control limits that were based on the current
estimated mean; thus, the control limits varied in a seasonal fashion along the the
estimated disease incidence.
One advantage of modeling the counts directly is that the resulting chart is easily
understood. Also, one can see from the plot the current situation along with the past
history of the disease. Figure 15 shows the incidence of pertussis in Missouri from
2002 to 2011. From this plot, the years when there was a pertussis outbreak are
obvious.
Perhaps most important for this discussion, many of the detection methods dis-
cussed in Section 2 are most effective when the systematic components of disease
surveillance data are removed. This is best accomplished by first modeling the data,
where the model is used to estimate the systematic effects, and then using the de-
tection methods on the model residuals. The residuals ri are what remain after the
modeled values are subtracted from the raw data, ri = xi− xˆi, and thus what is mon-
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Fig. 15 Pertussis counts in Missouri 2002-2011.
itored are changes from forecast values. Correctly done, the residuals may then be
independent, or nearly so, and then the industrial process monitoring methods of
Section 2 more appropriately apply. There are also cases where the disease counts
are modeled directly. See Fricker (2013, chapter 5) for a more in-depth discussion
about methods for modeling disease incidence data.
4.2 Detection Methods
The historical limits method is commonly used by public health practitioners to
compare data from a current time period to data from an equivalent historical period
or periods. The idea is to assess whether the current observed counts are significantly
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larger or smaller than equivalent historical totals after accounting for the natural
variation inherent in the data.
An example of a system that uses historical limits is the CDC’s National Notifi-
able Diseases Surveillance System (NNDSS). NNDSS aggregates and summarizes
data on specific diseases that health care providers are required by state law to re-
port to public health departments. Reportable diseases include anthrax, botulism,
plague, and tularemia.4 Each week the states report counts of cases for each of the
reportable diseases to the CDC.
A simple use of comparisons to historical data is the “Notifiable Diseases/Deaths
in Selected Cities Weekly Information” report published on-line each week in the
CDC’s Morbidity and Mortality Weekly Report (MMWR). Here the most recent
weekly totals for each of the notifiable diseases, Ti, j,k, for reportable disease i, in
week j and year k, are compared to the mean totals from similar weeks over the past
five years plus or minus two standard deviations:
Ti, j,k ≥ µˆi, j,k+2σˆi, j,k
or
Ti, j,k ≤ µˆi, j,k−2σˆi, j,k,






















Ti, j−r,k−s− µˆi, j,k
)2
,
This is just a specific form of the X¯-chart with two standard deviation limits.
Interestingly, rather than plot the data as a time series on a control chart, the
CDC uses a bar plot of the natural log-transformed (4-week) counts. For example,
Figure 16 is Figure I from “Notifiable Diseases/Deaths in Selected Cities Weekly
Information” for week 47 of 2009 (CDC, 2009), where for this week the mumps
count exceeded its historical limits as shown by the crosshatched top of the bar.
In the preceding example, a formal model of disease counts was not required as
comparisons to historical data were limited to those time periods in previous years
expected to be similar to the current period. This too is a model, but an informal one
which assumes that counts at the same time of the year are iid. For other types of
disease surveillance, particularly in biosurveillance, a more formal model may have
to be applied. Once done, many of the detection methods of Section 2, applied to
forecast residuals, are useful for monitoring disease incidence.
4 See www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm for a complete list of reportable diseases.
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Fig. 16 Figure I from “Notifiable Diseases/Deaths in Selected Cities Weekly Information” for the
week 47 of 2009 (CDC, 2009). For this week, the mumps count exceeded its historical limits.
Now, for some types of surveillance, only monitoring for increases in disease
incidence is of interest. A benefit of so doing is greater detection power for the
same rate of false positive signals. In such cases, it is only necessary to use an UCL
for Shewhart charts. Similarly, for the CUSUM, one only need calculate C+, using
Equation (5), and not C− using Equation (6), and signal at time i when C+i > h. For
the EWMA, in addition to only using the UCL, the EWMA can be “reflected” (in the
spirit of the CUSUM) to improve its performance in detecting increases (Crowder
& Hamilton, 1992). To do so, Equation (7) is modified to:
zi = max[µ0,λxi+(1−λ )zi−1]. (22)
With this modification, the EWMA statistic must always be greater than or equal
to µ0, meaning that it cannot drift too far downwards, and thus it will more readily
signal when a positive shift occurs. The method starts at z0 = µ0 and a signal is
generated as before when zi > h, where the UCL is
UCL = h= µ0+Lσˆ
√
λ
2−λ [1− (1−λ )
2t ].
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When run on standardized forecast residuals, so that µ0 = 0 and σ = 1, then
Equation (22) becomes
zi = max[0,λxi+(1−λ )zi−1]




2−λ [1− (1−λ )
2t ],





In a similar manner, Joner et al. (2008) propose a reflected MEWMA:
zi =
{
max[0,λ (zi−µ0)+(1−λ )zi−1], for i> 0
0, for i= 0 ,
where the maximum function is applied component-wise. As with the MEWMA




And, as before, the MEWMA detection method signals whenever zi > h.
Variants of the MCUSUM that make it directionally sensitive also exist. And, var-
ious multivariate spatio-temporal methods, which are important to disease surveil-
lance, have been proposed. See chapter 8 of Fricker (2013) for more detail.
4.3 Performance Metrics
Unfortunately, as yet there is no set of performance metrics that are commonly ac-
cepted throughout the disease and biosurveillance communities. Furthermore, be-
cause of the transient nature of disease outbreaks, the average run length metrics
of the industrial process monitoring are insufficient. Fricker (2013) proposes the
following metrics:
• Average time between false signals (ATFS) is the mean number of time periods it
takes for the EED method to re-signal after the method first signals, given there
are no outbreaks. Thus, the ATFS is the expected time between false signals.
• Conditional expected delay (CED) is the mean number of time periods it takes
for the method to first signal, given that an outbreak is occurring and that the
method signals during the outbreak. Thus, the CED is the expected number of
time periods from the start of an outbreak until the first true signal during that
outbreak.
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• Probability of successful detection (PSD) is the probability the method signals
during an outbreak, where the probability of detection is both a function of the
EED method and the type of outbreak.
The metrics are mathematically defined as follows. Let St denote a generic de-
tection method statistic at time t, whereS0 is the value of the statistic when the de-
tection method is first started. Let h denote the method’s threshold, where ifSt ≥ h
the method signals at time t. Also, let τs denote the first day of a disease outbreak,
where the notation τs = ∞ means that an outbreak never occurs, and let τe denote
that last day of an outbreak, where if τs =∞ then by definition τe =∞. Finally, let t∗
denote the first time the method signals, t∗ = min(t :St ≥ h), and let let t∗∗ denote
the next time the method signals, t∗∗ = min(t : t > t∗ andSt ≥ h).
Then
ATFS = E(t∗∗− t∗|St∗+1 =S0 and τs = ∞), (23)
CED = E(t∗− τs|τs ≤ t∗ ≤ τe), (24)
and
PSD = P(τs ≤ t∗ ≤ τe). (25)
Mathematically, the ATFS metric as defined in Equation (23) is the same as the
in-control ARL because after each signal the method’s statistic is re-set to its starting
value. However, some disease surveillance practitioners prefer not to re-set after
each signal, so in that case,
ATFS = E(t∗∗− t∗|τs = ∞). (26)
Note the difference between Equations (23) and (26): in the former, the statistic
is re-set to its starting value after each time the detection method signals, while in
the latter it is not. If the time series of statistics is autocorrelated, then the resulting
ATFS performance can be very different since, with autocorrelation, once a signal
has occurred in one time period more signals are likely to occur in subsequent peri-
ods.
Under the condition that the statistic is not re-set, Fraker et al. (2008) have
proposed the average time between signal events (ATBSE) metric, where a signal
event is defined as consecutive time periods during which an EED method signals.
Under theses conditions, the ATBSE may be a more informative measure, since it
quantifies the length of time between groups of signals, but it is also may not provide
sufficient information about the number of false positive signals that will occur.
The CED is conceptually similar to the out-of-control average run length in in-
dustrial process monitoring, but in that application when a process goes out of con-
trol it stays out of control so that the out-of-control ARL = E(t∗−τs|t∗ ≥ τs). Since
outbreaks are transient in disease surveillance the definition differs because it must
incorporate the idea that a signal is only useful if it occurs sometime during the
outbreak.
PSD does not have an analogue in the industrial process monitoring literature.
As defined above, it is the probability of detecting an outbreak at any time during
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the outbreak. For longer outbreaks this definition may be too loose, meaning that
detection later in the outbreak may not be medically useful. If that is the case, the
definition by Sonesson & Bock (2003) may be more operationally relevant:
PSD = P(t∗− τs ≤ d|τs ≤ t∗ ≤ τl),
where d is the maximum delay required for a successful detection, and where “suc-
cessful detection” means early enough in the outbreak that an intervention is medi-
cally effective.
4.3.1 Alternative Metrics
Fraker et al. (2008) note that “Substantially more metrics have been proposed in
the public health surveillance literature than in the industrial monitoring literature.”
These include run length and time to signal based metrics such as the ARL and
average time to signal (ATS). However, these metrics fail both to account for the
transient nature of disease outbreaks and that detection method statistics are often
not re-set after they signal. In comparison, when an industrial process goes out-
of-control it stays in that condition until the control chart signals and the cause is
identified and corrected. Thus, in industrial process monitoring, once a process goes
out of control any signal is a true signal, and so the probability of signaling during
an out-of-control condition is always 1. This is not the case in disease surveillance
where outbreaks are transient and after some period of time disappear. In this situa-
tion, it is possible for an detection method to fail to signal during an outbreak, after
which a signal is a false signal.
To overcome the issues associated with applying the control chart ARL metrics
to disease surveillance, various modifications have been proposed. For example,
Fraker et al. (2008) propose the average time between signal events (ATBSE),
where a signal event is defined as consecutive time periods during which an de-
tection method signals. They also define the average signal event length (ASEL)
as how long, on average, a detection method signals over consecutive time periods.
The ATBSE and ASEL metrics are designed for how disease surveillance systems
are often currently operated, where the detection methods are not re-set after they
signal. In this situation, disease surveillance system operators allow the detection
methods to continue to run after they signal and interpret the resulting sequence of
signals (or lack thereof) as additional information about a potential outbreak. Un-
der theses conditions, the ATBSE maybe preferred to the ATFS metric. See Fricker
(2013, chapter 6) for a more in-depth discussion of these and other metrics.
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Fig. 17 Plot of 2-1/2 years of GI syndrome data from a hospital. The dotted lines indicate a period
of “normal” (i.e., non-seasonal outbreak) disease incidence from days 220 to 400.
4.4 Detecting Seasonal Outbreaks: An Example
Consider the problem of detecting seasonal flu outbreaks. Figure 18 is a plot of
2-1/2 years of gastrointestinal (GI) syndrome data for one hospital that is a useful
syndromic surveillance surrogate for the flu. Note how, in retrospect, three episodes
of seasonal increases in GI are visually obvious. To illustrate prospectively detecting
seasonal increases, we turn the clock back to day 400 in order to define the param-
eters of the detection methods, and then run the methods forward from day 401 to
day 980.
So, given the historical data from days 1 to 400, one might decide that days 200
to 400, delineated by the dotted lines in Figure 17, best characterize normal (i.e.,

















(xi− µˆ0)2 = 4.5.
Ignoring day and other systematic effects potentially present in the data, one
approach is to simply standardize future observations with
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Fig. 18 Plot of the hospital GI syndrome data with signal times, where the Shewhart, CUSUM and
EWMA detection method signaling times are indicated with the vertical lines. Thresholds were set







, i= 401,402, . . .
and apply the Shewhart, CUSUM, and EWMA detection methods to the yi (with-
out re-setting after signals). For an average time between false signals (ATFS) of
365 days, assuming the standardized values are approximately normally distributed
(which a Q-Q plot shows is reasonable) set h = 2.7775 for the Shewhart, h = 1.35
and k = 1.5 for the CUSUM, and L= 2.815 and λ = 0.3 for the EWMA.
The results are shown at the top of Figure 18, where the signaling times for each
detection method are indicated by the short vertical lines. The figure shows that all
three detection methods clearly indicate the two large seasonal increases (after day
400) in GI. However, there are some differences in how they indicate the duration of
the outbreaks and, because the methods are not re-set, the CUSUM’s and EWMA’s
signals are more persistent.
In particular, note how the CUSUM continues to signal well after the two sea-
sonal increases have subsided. In addition, the EWMA and CUSUM detection meth-
ods tend to signal earlier because of the gradual increase in GI counts at the start
of the outbreaks. Finally, note that there are a couple of smaller potential outbreaks
in between the two larger outbreaks that are more obvious given the signals. See
Chapter 9 of Fricker (2013) for additional detail and further development of this
example.
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5 Further Reading
5.1 Industrial Process Monitoring
1. Montgomery, D.C. (2009). Introduction to Statistical Quality Control, John Wi-
ley & Sons.
5.2 Health Care Monitoring
1. Faltin, F., Kenett, R., and Ruggeri, F., editors (2012) Statistical Methods in
Healthcare, Wiley, West Sussex, UK.
2. Winkel, P. and Zhang, N. F. (2007) Statistical Development of Quality in Medicine,
Wiley, West Sussex, UK.
5.3 Disease Surveillance
1. Brookmeyer, R. and D.F. Stroup, eds. (2004). Monitoring the Health of Popula-
tions: Statistical Principles and Methods for Public Health Surveillance, Oxford
University Press.
2. Fricker, Jr., R.D. (2013). Introduction to Statistical Methods for Biosurveillance:
With an Emphasis on Syndromic Surveillance, Cambridge University Press.
3. Lombardo, J.S., and D.L. Buckeridge, eds. (2007). Disease Surveillance: A Pub-
lic Health Informatics Approach, Wiley-Interscience.
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